ADGM
Adagio Medical Holdings, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.48
−7.21%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$0.49
From 52W high−79.56%
Volume92465.00
Market cap$10.72M
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataSep 18, 2026
Open
$0.49
From 52W high
−79.56%
Volume
92465.00
Market cap
$10.72M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.2x
P/E (TTM)
—
RSI (14)
43.4
MomentumView details →
1D Return
−7.21%
YTD Return
−51.44%
SummaryUpdated Jun 1, 2026
Adagio Medical Holdings, Inc. (NASDAQ:ADGM) is a developmental stage medical device company founded in 2011 and headquartered in Laguna Hills, California. The company went public in July 2024 and specializes in developing advanced ablation technologies for treating cardiac arrhythmias, which are irregular heart rhythms that can be life-threatening if left untreated. Adagio focuses on innovative catheter-based solutions that use ultra-low temperature cryoablation and pulsed-field ablation techniques to restore normal heart rhythm in patients suffering from conditions like atrial fibrillation, atrial flutter, and ventricular tachycardia.
Similar companies
Latest newsMore news →
Adagio Medical Holdings, Inc. received a notice from Nasdaq on August 13, 2026, stating that it no longer complies with the minimum stockholders' equity requirement of Nasdaq Listing Rule 5550(b)(1).37d agoAdagio Medical Holdings, Inc. announced its financial results for the second quarter ended June 30, 2026.40d ago